The Office for Civil Rights in the US Department of Health and Human Services announced proposed changes to strengthen patients’ rights to access their own health information, improve care coordination, and reduce regulatory burdens.
As doctors prepared for a fall and winter COVID-19 surge across the U.S., they sounded alarms about inadequate supplies of the antiviral medication remdesivir to treat their patients.
has provided guidance to healthcare facilities and providers looking to use certain drugs beyond their labeled “in-use times” due to supply issues related to the coronavirus disease 2019 (COVID-19) pandemic.
Hand sanitizers containing methanol, or wood alcohol, present a danger to individuals as the substance can be toxic when absorbed through the skin or life-threatening if ingested.
Routine vaccination should not be delayed due to the COVID-19 pandemic, according to interim guidance released by the Centers for Disease Control and Prevention.
The American College of Physicians statement outlines how the “status quo” created health inequalities and prevented the spread of the COVID-19 virus, and outlines steps on how to move forward.
The American Board of Internal Medicine announced that certified physicians who have a Maintenance of Certification requirement due in 2020 will now have until the end of 2021 to complete it.
The guide includes information on a drug’s origin, common street names, how it is abused, what effect it has on the mind and body, what the overdose effects are, and what its legal status is in the US.
Results from a narrative review published in the Journal of Medical Ethics suggest broad yet conditional support for data sharing among patients and the general public, with many studies citing concerns about confidentiality, privacy, data security, risk management, and accountability.
